⌘K
Loading ticker…
As of 2026-08-21, Zenas BioPharma, Inc. Common Stock (ZBIO) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 64. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.4%, relative volume 1.08×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ZBIO is held by 21 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $2M notional. Top 3 carry $6M.
Held by 39 ETFs · $79M across latest filings · largest weight 0.63% (PTH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $878K |
| — |
| VTWV | 0.03% | $345K | — |
| ONEQ | 0.00% | $312K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $301K | — |
| GSSC | 0.03% | $287K | new |
Showing 10 of 21 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZBIO Jan avg: -25.74% median: -25.74% win: 0% σ: 33.47% n: 2 2024-09-16 → 2026-07-31 | ZBIO Feb avg: 15.42% median: 15.42% win: 50% σ: 39.62% n: 2 2024-09-16 → 2026-07-31 | ZBIO Mar avg: -6.55% median: -6.55% win: 50% σ: 27.22% n: 2 2024-09-16 → 2026-07-31 | ZBIO Apr avg: 22.70% median: 22.70% win: 50% σ: 33.77% n: 2 2024-09-16 → 2026-07-31 | ZBIO May avg: -11.28% median: -11.28% win: 0% σ: 9.21% n: 2 2024-09-16 → 2026-07-31 | ZBIO Jun avg: 19.86% median: 19.86% win: 100% σ: 25.56% n: 2 2024-09-16 → 2026-07-31 | ZBIO Jul avg: 43.00% median: 43.00% win: 100% σ: 27.05% n: 2 2024-09-16 → 2026-07-31 | ZBIO Aug avg: 1.85% median: 1.85% win: 100% σ: 0.00% n: 1 2024-09-16 → 2026-07-31 (current) | ZBIO Sep avg: 15.99% median: 15.99% win: 50% σ: 32.19% n: 2 2024-09-16 → 2026-07-31 | ZBIO Oct avg: 33.13% median: 33.13% win: 100% σ: 10.79% n: 2 2024-09-16 → 2026-07-31 | ZBIO Nov avg: -10.77% median: -10.77% win: 50% σ: 49.54% n: 2 2024-09-16 → 2026-07-31 | ZBIO Dec avg: -17.67% median: -17.67% win: 0% σ: 15.81% n: 2 2024-09-16 → 2026-07-31 |